Company Search:
Advanced Search
Sponsored Links
Cyclacel Pharmaceuticals, Inc. Company Snapshot
Cyclacel Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cyclacel Pharmaceuticals with three other companies in this sector in the United States: Abeona Therapeutics Inc (2016 sales of $889,000.00 ), Pulmatrix Inc ($835,000.00 ), and Conatus Pharmaceuticals Inc ($799,046.00 ).

Sales Analysis. Cyclacel Pharmaceuticals reported sales of $843,000.00 for the year ending December of 2016. This represents a sharp decrease of 56.6% versus 2015, when the company's sales were $1.94 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cyclacel Pharmaceuticals, Inc.
  Stock Performance Chart for Cyclacel Pharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 1.70
(Figures in U.S. Dollars)
1 Week 0.6%   13 Weeks -1.2%  
4 Weeks -10.1%   52 Weeks -67.6%  
Cyclacel Pharmaceuticals, Inc. Key Data:
  Ticker: CYCC Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 843,000
(Year Ending Jan 2017).
Employees: 13
  Currency: U.S. Dollars Market Cap: 20,237,686
  Fiscal Yr Ends: December Shares Outstanding: 11,904,521
  Share Type: Common Closely Held Shares: 2,299,978
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.